Trial intelligence / Profile preview

Phase II study of oral transmucosal fentanyl citrate for procedural analgesia during central venous catheterization in cancer patients

2012-002469-37Phase 2Completed

Sponsor
Centro di Riferimento Oncologico di Aviano
Start
Sep 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of fentanyl in cancer, sponsored by Centro di Riferimento Oncologico di Aviano. Primary endpoint: Analgesic efficacy of transmucosal fentanyl citrate. Started Sep 2012; status: completed.

02

Drugs

fentanyl
03

Conditions

cancer

Beyond the preview

Go deeper on 2012-002469-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-002469-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call